This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Latest News
Latest News
Norgine Ventures Management Limited, Norgine House, Widewater Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS UK. Norgine Ventures Management Limited is a limited company registered in England and Wales with company number 08723417. NORGINE and the sail logo are trademarks of the Norgine group of companies.
Norgine Ventures Management Limited is authorised and regulated by the Financial Conduct Authority, registration number 917803.
Investing in smaller and unlisted companies (which may be start-up or early stage businesses) involves risks. These risks include possible loss of capital, illiquidity and dilution. Such companies will often not pay dividends. You should not invest in any such company (or any fund that invests in such companies) unless you understand the risks involved, and have taken advice where necessary. A more detailed statement of risks involved can be found here Risk Warning.
Norgine Ventures Completes €15 Million Financing With Agendia N.V.
London. 14 March 2014. Norgine Ventures today announced that, together with a number of Agendia’s existing shareholders, it has provided debt financing of €15 million to Agendia NV, with Norgine leading the syndicate. This investment recognises the growth prospects of Agendia, a molecular diagnostic company marketing a suite of breast and colon cancer tests. The […]
Norgine Ventures Completes €5 Million Financing With Supersonic Imagine SA
London. 10 January 2014. Norgine Ventures today announced that it has provided financing of €5 million to SuperSonic Imagine SA. The financing was realised in form of private bonds with warrants. Norgine Ventures’ investment will enable SuperSonic Imagine to accelerate further technological development and commercial expansion in the US and in Asia. Norgine Ventures is […]
Norgine Ventures Completes £7.5 Million Debt Financing With Stanmore Implants
London. 13 December 2013, 07:00 AM GMT. Norgine Ventures today announced that it has provided debt financing of £7.5 million to Stanmore Implants Worldwide Ltd. This funding recognises the potential of Stanmore Implants, a pioneer in the global limb salvage and preservation orthopaedic implants markets. Norgine Ventures is a business entity of Norgine, a well-established […]
Norgine Ventures Completes £2 Million Debt Financing With Internis
London. 10 September 2013. Norgine Ventures today announced that it has provided debt financing of £2 million to Internis Pharmaceuticals. This funding recognises the potential of Internis, an exciting and innovative British start-up company. Norgine Ventures is a business entity of Norgine, a well-established independent pan-European pharmaceutical company. Norgine Ventures’ backing will enable Internis to […]